APA (7th ed.) Citation

LT, N., HP, N., HT, B., QT, N., PV, N., & HTT, H. (2026). Safety and preliminary efficacy of allogeneic umbilical cord-derived mesenchymal stem cells administered via the hepatic artery in patients with liver cirrhosis: A phase I open-label trial. Cell transplantation, 35, 9636897261449975. https://doi.org/10.1177/09636897261449975

Chicago Style (17th ed.) Citation

LT, Nguyen, Nguyen HP, Bui HT, Nguyen QT, Nguyen PV, and Ha HTT. "Safety and Preliminary Efficacy of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells Administered via the Hepatic Artery in Patients with Liver Cirrhosis: A Phase I Open-label Trial." Cell Transplantation 35 (2026): 9636897261449975. https://doi.org/10.1177/09636897261449975.

MLA (9th ed.) Citation

LT, Nguyen, et al. "Safety and Preliminary Efficacy of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells Administered via the Hepatic Artery in Patients with Liver Cirrhosis: A Phase I Open-label Trial." Cell Transplantation, vol. 35, 2026, p. 9636897261449975, https://doi.org/10.1177/09636897261449975.